首页|莱菔承气汤缓解无创呼吸机治疗中腹胀的效果

莱菔承气汤缓解无创呼吸机治疗中腹胀的效果

扫码查看
目的 观察慢性阻塞性肺疾病(COPD)患者在佩戴无创呼吸机治疗期间,服用莱菔承气汤对其产生腹胀的缓解效果.方法 选取2020年1月—2021年12月入住天津市胸科医院呼吸重症监护室(RICU),给予无创呼吸机治疗的46例患者为研究对象,随机分为对照组和研究组各23例.对照组采用常规护理,研究组在对照组基础上给予口服莱菔承气汤.观察比较两组患者腹胀缓解效果、肠鸣音计数、腹围评定及胃肠道症状的严重程度.结果 研究组腹胀缓解率为86.96%,高于对照组的21.74%,差异有统计学意义(x2=19.71,P<0.05).干预前,两组患者肠鸣音计数比较,差异无统计学意义(P>0.05);干预后,两组肠鸣音计数均较干预前增加,且研究组增加高于对照组,差异均有统计学意义(P<0.05).干预前,两组患者腹围评定比较,差异无统计学意义(P>0.05);干预后,两组患者腹围评定小于干预前,且研究组小于对照组,差异均有统计学意义(P<0.05).干预前,两组患者GSRS评分比较,差异无统计学意义(P>0.05);干预后,两组GSRS评分均低于干预前,且研究组评分低于对照组,差异均有统计学意义(P<0.05).结论 口服莱菔承气汤可有效缓解COPD患者由于无创呼吸机治疗而产生的腹胀情况,促进胃肠功能的恢复,可改善COPD患者机体内部环境,可在临床工作中推广应用.
Effect of Laifu Chengqi Decoction in relieving abdominal distension during non-invasive ventilation therapy
Objective To observe the alleviating effect of the Laifu Chengqi Decoction in relieving abdominal distension in chronic obstructive pulmonary disease(COPD)patients during non-invasive ventilation therapy.Methods From January 2020 to December 2021,46 COPD patients receiving non-invasive ventilation therapy were selected from the Respiratory Intensive Care Unit(RICU)of Tianjin Chest Hospital.They were randomly divided into control group and study group,with 23 patients in each group.The control group received routine nursing methods,while the study group received oral Laifu Chengqi Decoction on the basis of the control group.The relief effect of abdominal distension,bowel sound count,abdominal circumference assessment,and severity of gastrointestinal symptoms between two groups of patients were observed and compared.Results The relief rate of abdominal distension in the study group was 86.96%,which was higher than the control group's 21.74%,and the difference was statistically significant(x2=19.71,P<0.05).Before intervention,there was no statistically significant difference in the count of bowel sounds between the two groups of patients(P>0.05);after intervention,the counts of intestinal sounds in both groups increased compared to before intervention,and the increase in the study group was higher than that in the control group,and the differences were statistically significant(P<0.05).Before intervention,there was no statistically significant difference in abdominal circumference assessment between the two groups of patients(P>0.05);after intervention,the abdominal circumference assessment of both groups of patients were lower than those before intervention,and the study group was better than the control group,and the differences were statistically significant(P<0.05).Before intervention,there was no statistically significant difference in GSRS scores between the two groups of patients(P>0.05);after intervention,the GSRS scores of both groups were lower than those before intervention,and the GSRS score of the study group was lower than that of the control group,and the differences were statistically significant(P<0.05).Conclusion Oral administration of Laifu Chengqi Decoction could effectively alleviate bloating caused by non-invasive ventilator treatment in COPD patients,promote the recovery of gastrointestinal function,improve the internal environment of COPD patients,and could be promoted and applied in clinical practice.

Laifu Chengqi DecoctionChronic obstructive pulmonary diseaseNon-invasive ventilatorAbdominal distension

朱佳蕾

展开 >

天津市胸科医院呼吸科疾病护理RICU,天津 300222

莱菔承气汤 慢性阻塞性肺疾病 无创呼吸机 腹胀

2024

中国城乡企业卫生
中华预防医学会 天津市职业病防治院

中国城乡企业卫生

影响因子:0.239
ISSN:1003-5052
年,卷(期):2024.39(12)